Rhinomel Manuka Spray
NDC Package 73024-474-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Rhinomel Manuka (sodium chloride) sprays is a medication used to treat dryness inside the nose (nasal passages). This formulation utilizes a spray delivery system. Marketed by Melcare Biomedical Pty Ltd, this product is identified by NDC 73024-474.

Identification & Billing

NDC Package Code
73024-474-10
Package Description
1 BOTTLE, SPRAY in 1 CARTON / 20 mL in 1 BOTTLE, SPRAY
Product Code
11-Digit Billing Format
73024047410
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Rhinomel Manuka
Non-Proprietary Name
Sodium Chloride
Substance Name
Sodium Chloride
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Nasal - Administration to the nose; administered by way of the nose.
Active Ingredient(s)
Usage Information
This product is used to treat dryness inside the nose (nasal passages). It helps add moisture inside the nose to dissolve and soften thick or crusty mucus. In babies and young children with stuffy noses who cannot blow their noses, using this product helps to make the mucus easier to remove with a nasal bulb syringe. This helps relieve stuffiness and makes breathing easier. This product contains a purified gentle salt solution (also called saline or sodium chloride solution). It does not contain any medication.

Regulatory & Marketing

Labeler Name
Melcare Biomedical Pty Ltd
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
05-21-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 73024-474-10 identifies a specific commercial package of 1 bottle, spray in 1 carton / 20 ml in 1 bottle, spray of Rhinomel Manuka, a human over the counter drug labeled by Melcare Biomedical Pty Ltd. This spray is formulated for nasal use and contains sodium chloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Melcare Biomedical Pty Ltd on May 21, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This product is used to treat dryness inside the nose (nasal passages). It helps add moisture inside the nose to dissolve and soften thick or crusty mucus. In babies and young children with stuffy noses who cannot blow their noses, using this product helps to make the mucus easier to remove with a nasal bulb syringe. This helps relieve stuffiness and makes breathing easier. This product contains a purified gentle salt solution (also called saline or sodium chloride solution). It does not contain any medication.

How is this Melcare Biomedical Pty Ltd product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 73024047410. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
73024-474-10
11-Digit CMS (5-4-2)
73024-0474-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.